Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,289 | -1,625 | -903 | -1,886 | -2,037 |
| Depreciation Amortization | 5 | 5 | 3 | 10 | 7 |
| Accounts receivable | 1,071 | 1,066 | 842 | -360 | -423 |
| Other Working Capital | 1,291 | 1,012 | 772 | -163 | -18 |
| Other Operating Activity | -827 | -1,014 | -718 | 3,023 | 2,353 |
| Operating Cash Flow | $-750 | $-556 | $-5 | $624 | $-118 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2 | -2 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 288 | 286 |
| Debt Repayment | -43 | -43 | -21 | -102 | -69 |
| Common Stock Issued | 127 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -63 | -44 | -9 | -46 | -35 |
| Financing Cash Flow | $21 | $-87 | $-31 | $139 | $182 |
| Exchange Rate Effect | 0 | 4 | -39 | 53 | 3 |
| Beginning Cash Position | 881 | 892 | 888 | 68 | 68 |
| End Cash Position | 153 | 253 | 813 | 883 | 133 |
| Net Cash Flow | $-728 | $-639 | $-75 | $815 | $66 |
| Free Cash Flow | |||||
| Operating Cash Flow | -750 | -556 | -5 | 624 | -118 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -750 | -556 | -5 | 624 | -120 |